Johnson & Johnson (JNJ)
265.89
+2.49
(+0.95%)
USD |
NYSE |
Jul 27, 16:00
269.01
+3.12
(+1.17%)
After-Hours: 20:00
Johnson & Johnson EPS Diluted (Quarterly) : 2.268 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.268 |
| March 31, 2026 | 2.141 |
| December 31, 2025 | 2.098 |
| September 30, 2025 | 2.121 |
| June 30, 2025 | 2.289 |
| March 31, 2025 | 4.538 |
| December 31, 2024 | 1.414 |
| September 30, 2024 | 1.110 |
| June 30, 2024 | 1.935 |
| March 31, 2024 | 1.339 |
| December 31, 2023 | 1.666 |
| September 30, 2023 | 1.978 |
| June 30, 2023 | 1.959 |
| March 31, 2023 | -0.0261 |
| December 31, 2022 | 1.328 |
| September 30, 2022 | 1.675 |
| June 30, 2022 | 1.804 |
| March 31, 2022 | 1.931 |
| December 31, 2021 | 1.774 |
| September 30, 2021 | 1.371 |
| June 30, 2021 | 2.350 |
| March 31, 2021 | 2.319 |
| December 31, 2020 | 0.6511 |
| September 30, 2020 | 1.331 |
| June 30, 2020 | 1.360 |
| Date | Value |
|---|---|
| March 31, 2020 | 2.17 |
| December 31, 2019 | 1.502 |
| September 30, 2019 | 0.6566 |
| June 30, 2019 | 2.083 |
| March 31, 2019 | 1.389 |
| December 31, 2018 | 1.12 |
| September 30, 2018 | 1.44 |
| June 30, 2018 | 1.45 |
| March 31, 2018 | 1.60 |
| December 31, 2017 | -3.99 |
| September 30, 2017 | 1.37 |
| June 30, 2017 | 1.40 |
| March 31, 2017 | 1.61 |
| December 31, 2016 | 1.38 |
| September 30, 2016 | 1.53 |
| June 30, 2016 | 1.43 |
| March 31, 2016 | 1.59 |
| December 31, 2015 | 1.15 |
| September 30, 2015 | 1.20 |
| June 30, 2015 | 1.61 |
| March 31, 2015 | 1.53 |
| December 31, 2014 | 0.89 |
| September 30, 2014 | 1.66 |
| June 30, 2014 | 1.51 |
| March 31, 2014 | 1.64 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Pfizer Inc. | 0.4688 |
| Bristol Myers Squibb Co. | 1.308 |
| Abbott Laboratories | 0.5324 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.534B |
| Revenue (Quarterly) | 25.32B |
| Total Expenses (Quarterly) | 19.78B |
| Enterprise Value | 662.61B |
| Gross Profit Margin (Quarterly) | 68.73% |
| Profit Margin (Quarterly) | 21.86% |
| Earnings Yield | 3.24% |
| Operating Earnings Yield | 4.08% |
| Normalized Earnings Yield | 3.565 |